PARAGON-HF - Why We Do Randomized, Controlled Clinical Trials

N Engl J Med. 2019 Oct 24;381(17):1675-1676. doi: 10.1056/NEJMe1912402.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Angiotensins
  • Heart Failure*
  • Humans
  • Neprilysin*
  • Stroke Volume

Substances

  • Angiotensins
  • Neprilysin